Ronald A. Booth

Ronald A. Booth

Auto-generated profile, based on publicly available information

Ronald A. Booth

Department of Pathology and Laboratory Medicine, Eastern Ontario Regional Laboratory Association and Ottawa Hospital Research Institute, University of Ottawa & The Ottawa Hospital, Ottawa, ON K1H8L6, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2020 in Biomedicines
Verified
Journal Article
Open access
PDF file
STSimon Thebault
Simon Thebault
RBRonald A. Booth
Ronald A. Booth
MFMark S. Freedman
Mark S. Freedman
Blood neurofilament light chain (NfL) is a marker of neuro-axonal injury showing promising associations with outcomes of interest in several neurological conditions. Although initially discovered and investigated in the cerebrospinal fluid (CSF), the recent development of ultrasensitive digital immunoassay technologies has enabled reliable detection in serum/plasma, obviating the need for invasive lumbar punctures for longitudinal assessment. The most evidence for utility relates to multiple sclerosis (MS) where it serves as an objective measure of both the inflammatory and degenerative pathologies that characterise this disease. In this review, we summarise the physiology and pathophysiology of neurofilaments before focusing on the technological advancements that have enabled reliable quantification of NfL in blood. As the test case for clinical translation, we then highlight important recent developments linking blood NfL levels to outcomes in MS and the next steps to be overcome before this test is adopted on a routine clinical basis.